We have been developing 2-deoxy-D-glucose (2-DG), an analog of glucose, as a non-toxic anti-cancer agent and in an FDA-approved Phase
The following is a review of the literature and evidence supporting the anti-viral properties of 2-DG, lending further credence to our hypothesis that it can be used as a possible treatment for COVID-19. We are